|1.||Walker, J Michael: 2 articles (08/2006 - 10/2002)|
|2.||Hunt, Mary C: 1 article (05/2012)|
|3.||Waluk, Dominik P: 1 article (05/2012)|
|4.||Sucharski, Filip: 1 article (05/2012)|
|5.||Sipos, Laszlo: 1 article (05/2012)|
|6.||Silberring, Jerzy: 1 article (05/2012)|
|7.||Inoue, Kazuhiko: 1 article (02/2012)|
|8.||Miyata, Atsuro: 1 article (02/2012)|
|9.||Takenouchi, Rina: 1 article (02/2012)|
|10.||Kambe, Yuki: 1 article (02/2012)|
12/25/2009 - "N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. "
08/23/2002 - "The lipoamino acid N-arachidonylglycine (NAGly) has also been shown to suppress tonic inflammatory pain and is naturally present at significant levels in many of the same mammalian tissues that express COX-2. "
05/11/2012 - "N-Oleoyl glycine and N-arachidonoyl glycine are structurally and functionally related to endocannabinoids and have been identified as signaling molecules that regulate functions like the perception of pain and body temperature and also have anti-inflammatory properties. "
11/16/2001 - "We show that the conjugate of arachidonic acid and glycine (N-arachidonylglycine (NAGly)) is present in bovine and rat brain as well as other tissues and that it suppresses tonic inflammatory pain. "
10/01/2002 - "N-arachidonylglycine (NAGly), the carboxylic analog of the endocannabinoid anandamide, occurs in rat and bovine brain as well as in peripheral sites and shows activity against tonic, formalin-induced pain. "
|2.||Glycine (Aminoacetic Acid)
|4.||Arachidonic Acid (Vitamin F)